Hepatitis B and Hepatitis C
Facts & Figures

Hepatitis B (HBV)

Facts & Figures
An estimated 1.25 million people are chronically infected with HBV in the U.S., with 20 to 30% acquiring their infection in childhood (CDC)
Approximately 78,000 new HBV infections occur every year (CDC)
15-25% of chronically infected persons will die from liver disease
Chronic HBV infection occurs in:
90% of infants infected at birth
30% of children infected at age 1-5 years
6% of persons infected after age 5 years
Highest rate of disease occurs in 20-49 year-olds
30% of infected individuals are asymptomatic - symptoms are less common in children than adults (CDC)
Concurrent chronic HBV/HCV infection appears to increase the risk of progressive liver disease (NIH consensus statement)

HBV Risk Groups
At risk sexual behavior
Multiple sex partners
Men sex with men
Individuals diagnosed with an STD
Intravenous drug users
Hemodialysis patients
Individuals living with chronically infected persons
Infants born to infected mothers
Healthcare workers

In developed countries like the U.S., HBV infection is prevalent in immigrant populations from endemic areas such as:
Asia
South Pacific region
Sub-Saharan Africa
Australia
New Zealand
Populations in South America
Middle East
Certain indigenous arctic populations

Hepatitis C (HCV)

Facts & Figures
An estimated 3.9 million people have been infected in the U.S. with HCV
Approximately 36,000 new HCV infections occur every year (CDC)
HCV is the most common chronic blood borne infection in the U.S. (CDC)
10,000 to 12,000 deaths yearly are attributed to HCV in the U.S. (NIH Consensus Statement)
30 to 40% of chronically infected persons are asymptomatic and have normal ALT levels (CDC)
A four-fold increase in the number of adults diagnosed with HCV is projected from 1990 to 2015 (NIH consensus statement)
60 to 85% of HCV infected individuals develop chronic infection (NIH Consensus Statement)
HCV is the primary reason for liver transplantation in the U.S. (NIH Consensus Statement)
HCV is the leading cause of death in HIV/HCV co-infected patients

HCV Risk Groups
Intravenous drug users
Individuals infected with HIV or HBV
Recipients of clotting factors made before 1987
Hemodialysis patients
Recipients of blood and/or solid organs before 1992
People with undiagnosed liver problems
Infants born to infected mothers

< Back to previous page